@WashURadOnc | DL/ML, genomics and bioinformatics enthusiast | Tweets are my own
St Louis, MO
Joined May 2019
- Tweets46
- Following300
- Followers244
- Likes429
Mike Waters, MD PhD retweeted
Thank you @NiuSanford ! Congrats to the @WashUMedRadOnc team for providing these additional data to guide treatment for this very challenging clinical scenario.
SBRT (50Gy/5fx, MR adaptive) in locally recurrent PDAC.
N=46 (7 w prior RT). 1 year LC 73%, median OS 19 mo.
Ablative RT = feasible, safe in locally recurrent setting & can confer long term dz control.
Great to see this data published - congrats @adapthyun & team! @OncoAlert
Mike Waters, MD PhD retweeted
The @WashUOTM hosted the 9th annual Celebration of Inventors! Recent patent awardees @gdhugo, Phillip Cuculich, MD & @SBRT_CR were honored for their patents in non-invasive imaging & treatment for cardiac arrhythmias.
otm.wustl.edu/washu-celebrat…
Mike Waters, MD PhD retweeted
Just published AND featured on the cover @CR_AACR with associated commentary!
Congrats to @titosandoval84 and team in the @JulieSchwarz14 Lab for this new paper where they look at how chemoradiation reshapes cervical tumors.
bit.ly/4sKlli6
Mike Waters, MD PhD retweeted
Protocol Activation! NRG-CC017: A randomized phase III study comparing temporally-modulated pulsed radiation therapy (TMPRT) versus standard radiation therapy with temozolomide for adults with newly diagnosed MGMT-unmethylated glioblastoma conta.cc/3PKI3bl
Mike Waters, MD PhD retweeted
Our review article is finally out. A labor of love and a year worth of work. The best part is I got to do it with my mentee🩷. Many thanks to @gabe_brewer for the invitation, guidance, and insight and for the dedicated reviewers for great feedback. nature.com/articles/s41568-0…
Mike Waters, MD PhD retweeted
New in the #RedJournal: A novel focal duodenal radiation injury model reveals dose-, time-, and spatially-dependent microbiome perturbations after radiation injury @LeMoyneHabimana. tinyurl.com/habimana1
Mike Waters, MD PhD retweeted
Our @SitemanCenter @BarnesJewish St Peters team, led by @lannis_hall got to share knowledge with South Korea! Dr. Song came here to learn more about our advanced technique with #prostatecancer seeds #brachytherapy. Global knowledge sharing helps patients!
bit.ly/47dcu00
Mike Waters, MD PhD retweeted
Another milestone for the @washumedicine @WashUCardiology collaboration STAR for ventricular tachycardia - 10 yrs after poster presentation, @DoctorPhillEP @SBRT_CR give the keynote at the #ASTRO25 Presidential Symposium! Amazing!
Mike Waters, MD PhD retweeted
Siteman Investment Program @SitemanCenter awarded grants to multiple researchers totaling over $2.4 Million! Three of our #radonc physicians received funding to conduct #clinicaltrials & #cancerresearch. Congrats @carmenbergom, @CarlDeSelm & @adapthyun!
bit.ly/4lOlzR1
Mike Waters, MD PhD retweeted
JUST PUBLISHED @NatureComms! Research led by Tianyi Liu, Felix Feng & @CarlDeSelm discovered cancer cells have a "repair crew" led by ATG9A that quickly fixes damage caused by macrophages! This gives new strategies for effective immune therapies. rdcu.be/euijG
Mike Waters, MD PhD retweeted
If you are @ESTRO_RT, PGY-5 @LeMoyneHabimana will be presenting his proffered paper in #Radiobiology.
May 3, 5pm local time: "A focal duodenal radiation injury model for investigating duodenal and stool microbiome dynamics in acute and late phase radiation injury" 👏
#ESTRO25
Mike Waters, MD PhD retweeted
Fantastic work by our physics, therapy and leadership teams. Glad to be back online! @ViewRaySystems @SitemanCenter
Today our team successfully completed an adaptive treatment, once again utilizing our @viewray #MRIdian machine! Very thankful for the BJC/WashU teams that collaborated, & the many hours devoted to making it happen. A BIG WIN for patients @SitemanCenter!
Mike Waters, MD PhD retweeted
Was a privilege to kick off the @UCJointCPH fall lecture series! You can check out the recording at the CPH Youtube page below:
youtu.be/GAf4yc61gv8?si=rT2j…
@UCSF_BCHSI @UCSFCancer @UCSF_DOCIT #radonc
.@julian_hong inaugurates CPH's fall lecture series on developing, deploying, and regulating medical AI. Leading experts in the field speak Thursdays, 10-11 AM, starting September 26. Via Zoom webinar. Register here: buff.ly/3XC8tML @UCSF_BCHSI @UCSFCancer #ML4H
Join us tomorrow for Part 1 of our 3-part series on the rise of generative AI! I'll kick off with Dr. Gibbs to dive into what generative AI is and its rapid rise. Next, @DrJohnKang will explore its impact on healthcare, @franklinliu1019 wraps up with RadOnc-GPT & AI in RadOnc!
There's still time to register for tomorrow's FREE #RSSWebinar "Overview of Generative AI: Promises and Pitfalls" (10/8 at noon ET) presented by Michael Waters, MD, PHD @MikeWaters121 and moderated by Iris Gibbs, MD. Register now at therss.org/education/webinar…
Mike Waters, MD PhD retweeted
We think cervical cancer mortality is unacceptable and are grateful that @NIH @theNCI @ConquerCancerFd and @SitemanCenter agree, supporting our multi-faceted approach to improve outcomes for our patients. Also, hiring - please contact me to tackle this problem with us
ALT Transmission electron micrograph of cervical cancer cell dying by lysosome-mediated death after radiation
Principal Investigator @SMarkovina2 has been awarded another grant for her work in #cervicalcancer. In fact, this is Dr. Markovina's 4th grant received this year! 👏🔬🙌
bit.ly/3TxHpgr
Lab website: markovinalab.wustl.edu/
Mike Waters, MD PhD retweeted
#LargeLanguageModels to Help Appeal Denied Radiotherapy Services: brnw.ch/21wMW2N
@WashURadOnc @MikeWaters121 #RadOnc
Mike Waters, MD PhD retweeted
First patient treated on our adaptive proton trial today❗ Thank you to this patient and Drs. Zhang, Liu, Zhao, Kim, Perkins and the rest of the adaptive radiation team @WashURadOnc for making this happen! @SitemanCenter #adaptiveRT #radonc
Mike Waters, MD PhD retweeted
Big thanks to @lauren_henke, @SBRT_CR, @APrice_BeamOn and our whole @WashURadOnc team on this trial! Per usual, it was a team effort ⚡️
Sim free/direct to unit #adaptiveRT for spine oligometastases was feasible and safe in this prospective pilot study ☢️
Congrats to @JoshuaSchiffMD on presenting a prospective clinical trial on sim-free/direct-to-unit adaptive radiotherapy, this time for spine SBRT for oligometastasia using an #MRLinac system at @ESTRO_RT with methods overview here:
Mike Waters, MD PhD retweeted
🚨New study led by Izzy Friesner (now @CUMedicalSchool med student) with @Jean_J_Feng, @NitinOhri3 + team @MontefioreNYC!
We developed a #machinelearning approach with #wearables to predict hospitalization during #cancer treatment
@UCSFCancer @UCSF_BCHSI @UCJointCPH #radonc 1/3
A machine learning approach with daily step counts from wearable devices from three prospective trials to predict unplanned hospitalization of patients undergoing chemoradiation was developed and validated in this study. ja.ma/4ax3WA1
